SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has expanded the clinical footprint of its SSi Mantra surgical robotic system with the launch of a robotic cardiac surgery program at HCG Hospital, Mithakhali, in Ahmedabad, India. According to the company, the program began with a robotic left internal mammary artery (LIMA) take-down performed using the SSi Mantra 3.0 system. The procedure was led by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, with support from the SS Innovations team.
In a LinkedIn post, the company congratulated Dr. Brajmohan Sinh, Dr. Lalit Malik, and the entire team at HCG Hospital for the achievement, thanking them for their trust and commitment in advancing robotic cardiac surgery in the region. “At SS Innovations International, Inc. we remain committed to enabling hospitals and…” the post continued, before directing readers to Read More>>.
The expansion comes as SS Innovations reported 238 SSi Mantra systems installed as of September 8, up 42% from the end of 2025. The system is now installed across 12 countries, with recent expansion into Colombia, Sri Lanka and the Philippines. The company is also pursuing U.S. FDA review and European Union CE marking as it seeks to expand SSi Mantra into additional international markets.
For investors and industry observers, the new cardiac program at HCG Hospital matters because it demonstrates the SSi Mantra’s versatility beyond general surgery. Cardiac procedures are among the most complex in robotic surgery, and successful adoption in this specialty could accelerate hospital adoption worldwide. The installation growth and geographic diversification also signal strong commercial momentum. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.
The announcement was distributed via InvestorWire, a specialized communications platform focused on wire-grade press release syndication. InvestorWire is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN, and a full array of tailored corporate communications solutions.
As SS Innovations continues to push into new markets and clinical applications, the HCG Hospital program serves as a proof point for the SSi Mantra’s potential in cardiac surgery. With regulatory clearances pending in the U.S. and Europe, the company’s ability to replicate such programs globally will be key to its growth trajectory.
